Impact of Routine Measurement of Serum Calcitonin on the Diagnosis and Outcome of Medullary Thyroid Cancer: Experience in 10,864 Patients with Nodular Thyroid Disorders

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 1, 2004, Pages 163-168

  Elisei, Rossella ^a   Bottici, Valeria ^a   Luchetti, Fabiana ^a   Di Coscio, Giancarlo ^a   Romei, Cristina ^a   Grasso, Lucia ^a   Miccoli, Paolo ^a   Iacconi, Pietro ^a   Basolo, Fulvio ^a   Pinchera, Aldo ^a   Pacini, Furio ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN;

ADOLESCENT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGRESSION; CANCER SCREENING; CANCER SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NODULAR GOITER; OUTCOMES RESEARCH; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; THYROID MEDULLARY CARCINOMA;

ADULT; AGED; BIOPSY, NEEDLE; CALCITONIN; CARCINOMA, MEDULLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; REMISSION INDUCTION; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; THYROID NEOPLASMS; THYROID NODULE; TIME FACTORS;

EID: 10744223544     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030550     Document Type: Article

References (36)

1. Williams ED, Brown CL, Doniach I 1966 Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid. J Clin Pathol 19:103-113
2. Gharib H, McConahey WM, Tiegs RD, Bergstralh EJ, Goellner JR, Grant CS, van Heerden JA, Sizemore GW, Hay ID 1992 Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clin Proc 67:934-940
3. Wells Jr SA, Baylin SB, Leight GS, Dale JK, Dilley WG, Farndon JR 1982 The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma. Ann Surg 195:595-599
4. van Heerden JA, Grant CS, Gharib H, Hay ID, Ilstrup DM 1990 Long-term course of patients with persistent hypercalatoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212:395-400
5. Moley JF, Wells SA, Dilley WG, Tisell LE 1993 Reoperation for recurrent or persistent medullary thyroid cancer. Surgery 114:1090-1095
6. Pacini F, Romei C, Miccoli P, Elisei R, Molinaro E, Mancusi F, Iacconi P, Basolo F, Martino E, Pinchera A1995 Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations. Surgery 118:1031-1035
7. Pacini F, Martino E, Romei C, Ceccherini I, Basolo F, Iacconi P, Pinchera A 1994 Treatment of preclinical medullary thyroid carcinoma in MEN 2A gene carrier. Lancet 344:1084-1085
8. Dralle H, Gimm O, Simon D, Frank-Raue K, Gortz G, Niederle B, Wahl RA, Koch B, Walgenbach S, Hampel R, Ritter MM, Spelsberg F, Heiss A, Hinze R, Hoppner W1998 Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 22:744-750
9. Wells Jr SA, Skinner MA 1998 Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes. Exp Clin Endocrinol Diabetes 106:29-34
10. Tashjian Jr AH, Howland BG, Melvin KEW, Hill Jr CS 1970 Immunoassay of human calcitonin. Clinical measurement, relation to serum calcium and studies in patients with medullary thyroid carcinoma. N Engl J Med 283:890-895
11. Pacini F, Basolo F, Elisei R, Fugazzola L, Cola A, Pinchera A 1991 Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens Am J Clin Pathol 95:300-308
12. Milhaud G, Calmette C, Taboulet J, Julienne A, Moukhtar MS 1974 Hypersecretion of calcitonin in neoplastic conditions. Lancet 16:462-463
13. LiVolsi VA 1997 C cell hyperplasia/neoplasia. J Clin Endocrinol Metab 82: 39-41
14. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A 1994 Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78:826-829
15. Rieu M, Lame MC, Richard A, Lissak B, Sambort B, Vuong-Ngoc P, Berrod JL, Fombeur JP 1995 Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules. Clin Endocrinol (Oxf) 42:453-460
16. Niccoli P, Wion-Barbot N, Caron P, Henry JF, de Micco C, Saint Andre JP, Bigorgne JC, Modigliani E, Conte-Devolx B 1997 Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. J Clin Endocrinol Metab 82: 338-341
17. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhausl A, Niederle B 1997 Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 82:1589-1593
18. Kaserer K, Scheuba C, Neuhold N, Weinhausel A, Vierhapper H, Haas OA, Niederle B 1998 C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 22:722-728
19. Ozgen AG, Hamulu F, Bayraktar F, Yilmaz C, Tuzun M, Yetkin E, Tuncyurek M, Kabalak T 1999 Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid cardnoma in seven hundred seventy-three patients with nodular goiter. Thyroid 9:579-582
20. Hahm JR, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ, Yang JH, Chung JH 2001 Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 11:73-80
21. Rago T, Vitti P, Chiovato L, Mazzeo S, De Liperi A, Miccoli P, Viacava P, Bogazzi F, Martino E, Pinchera A 1998 Role of conventional ultrasonography and color flow-Doppler sonography in predicting malignancy in 'cold' thyroid nodules. Eur J Endocrinol 138:41-46
22. LiVolsi VA 1997 C cell hyperplasia/neoplasia. J Clin Endocrinol Metab 82: 39-41
23. Hermanek P, Sobin LH 1987 UICC TNM classification of malignant tumors, 4th Ed. Berlin: Springer-Verlag
24. Bieglmayer Ch, Niederle B, Vierhapper H 2002 Interference causes false high calcitonin levels with a commercial assay. J Endocrinol Invest 25:197
25. Tommasi M, Brocchi A, Cappellini A, Raspanti S, Mannelli M 2001 False serum calcitonin high levels using a non-competitive two-site IRMA. J Endocrinol Invest 24:356-360
26. Oertel YC, Zorsky PE 1993 Fine needle aspiration as a means to cost-effective health care. South Med J 86:282-284
27. Geddie WR, Bedard YC, Strawbridge HT 1984 Medullary carcinoma of the thyroid in fine-needle aspiration biopsies. Am J Clin Pathol 82:552-558
28. Soderstrom N, Telenius-Berg M, Akerman M 1975 Diagnosis of medullary carcinoma of the thyroid by fine needle aspiration biopsy. Acta Med Scand 197:71-76
29. Kaur A, Jayaram G 1990 Thyroid tumors: cytomorphology of medullary, clinically anaplastic, and miscellaneous thyroid neoplasms. Diagn Cytopathol 6:383-389
30. Autelitano F, Santeusanio G, Mauriello A, Autelitano M, Palmieri G, Orlandi A, Spagnoli LG 1992 Latent pathology of the thyroid: an epidemiological and statistical study of thyroids sampled during 507 consecutive autopsies. Ann Ital Chir 63:761-781
31. Bondeson L, Ljunberg O 1981 Occult thyroid carcinoma at autopsy in Malmo, Sweden. Cancer 47:319-323
32. Komorowski RA, Hanson GA 1988 Occult thyroid pathology in the young adult: an autopsy of 138 patients without clinical thyroid disease. Hum Pathol 19:689-696
33. Furmanchuk AW, Roussak N, Ruchti C 1993 Occult thyroid carcinomas in the region of Minsk, Belarus. An autopsy study of 215 patients. Histopathology 23:319-325
34. Lang W, Borrisch H, Bauer L 1988 Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies. Am J Clin Pathol 90:72-76
35. Dunn JT 1994 When is a thyroid nodule a sporadic medullary carcinoma? J Clin Endocrinol Metab 78:824-825
36. Sheppard MC 1995 Should serum calcitonin be measured routinely in all patients with nodular thyroid disease? Clin Endocrinol (Oxf) 42:451-452